Join today and have your say! It’s FREE!

Become a member today, It's free!

We will not release or resell your information to third parties without your permission.
Please Try Again
{{ error }}
By providing my email, I consent to receiving investment related electronic messages from Stockhouse.

or

Sign In

Please Try Again
{{ error }}
Password Hint : {{passwordHint}}
Forgot Password?

or

Please Try Again {{ error }}

Send my password

SUCCESS
An email was sent with password retrieval instructions. Please go to the link in the email message to retrieve your password.

Become a member today, It's free!

We will not release or resell your information to third parties without your permission.
Quote  |  Bullboard  |  News  |  Opinion  |  Profile  |  Peers  |  Filings  |  Financials  |  Options  |  Price History  |  Ratios  |  Ownership  |  Insiders  |  Valuation

Medivolve Inc MEDVF

Medivolve, Inc. is a Canada-based healthcare technology company. The Company has two business units: Medivolve Pharmacy Division (MPD) and Collection Sites Diagnostics (CSD). MPD provides retail pharmacy and mail-order pharmacy services related to COVID-19, antibiotics, dermatology, family medicine, immunology, neurology, pain management, pediatrics, preventive medicine, and psychiatry to patients in Southern California. CSD’s software platform, Electronic Health Records app (EHR), is focused on supporting clinical staff, is a series of assets and functionalities that enhance the customer experience and provide an end-to-end lab solution. The Company, through its subsidiaries, Medivolve Pharmacy Inc., and Kedy Ying Jao D.O., a medical corporation, operate a distributed network of two retail patient-care locations in California, United States. The Company has served hundreds of thousands of patients across the United States and facilitated more than 1,533,000 clinical tests.


OTCPK:MEDVF - Post by User

Comment by Sarb99on Nov 24, 2020 7:23pm
133 Views
Post# 31966526

RE:This Site All Booked today, tomorrow until 1:20 pm Nov 26th

RE:This Site All Booked today, tomorrow until 1:20 pm Nov 26thYes Jimmy, upside here is mind boggling.

We now can see most of these testing sites are busy. Making money every day, every hour for QuestCap and indirectly for us shareholders.
 
Here is an example of revenue these testing sites can generate
 
20x150=3000 test a day then average price lets say $75 per test (I pick this number from the middle of $59 antibody test $99 Antiget and $179 PCR) 3000x$75=$225,000 a day and $6.75 million per month. Which is a lot of money for any penny stock but not for QuestCap as once QuestCap start adding more sites from 20 testing site to 40 then 40 testing sites to 80 and then 80 testing sites to 160 to over 400 testing sites by the end of December. Every time QuestCap increases these testing sites to double,  revenue amounts to double. Once QuestCap does launch 400+ testing sites, these revenues become huge.  
 
Just alone today 1800 people died in the USA. 

JimmyBaggs wrote: While I agree this is a tremndous return,  I still think you are aiming too small

Sarb please correct me if im wrong but I believe we calculated a value of 2 cents per cube at 37% capacity

We now know the demand is much higher but lets use that number to be conservative,  500 cubes x 2 cents a cube = $10

It seems almost insane when you start doing the math for 1000, 2000 etc but the math is solid and as Wembley pointed out,  it gets exciting very fast

MPO


Sarb99 wrote: Here is another collection site, all booked for today, all booked for tomorrow. Earliest available time to make an appointment is November 26, 2020 at 1:20 pm  




<< Previous
Bullboard Posts
Next >>